Your browser doesn't support javascript.
loading
Defining 'T cell exhaustion'.
Blank, Christian U; Haining, W Nicholas; Held, Werner; Hogan, Patrick G; Kallies, Axel; Lugli, Enrico; Lynn, Rachel C; Philip, Mary; Rao, Anjana; Restifo, Nicholas P; Schietinger, Andrea; Schumacher, Ton N; Schwartzberg, Pamela L; Sharpe, Arlene H; Speiser, Daniel E; Wherry, E John; Youngblood, Benjamin A; Zehn, Dietmar.
Afiliação
  • Blank CU; Netherlands Cancer Institute, Amsterdam, Netherlands. c.blank@nki.nl.
  • Haining WN; Discovery Oncology, Merck Research Laboratories, Boston, MA, USA. nick.haining@merck.com.
  • Held W; Department of Oncology, University of Lausanne, Lausanne, Switzerland. Werner.held@unil.ch.
  • Hogan PG; La Jolla Institute for Immunology, La Jolla, CA, USA. phogan@lji.org.
  • Kallies A; University of California, San Diego, La Jolla, CA, USA. phogan@lji.org.
  • Lugli E; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia. axel.kallies@unimelb.edu.au.
  • Lynn RC; Laboratory of Translational Immunology and Humanitas Flow Cytometry Core, Humanitas Clinical and Research Center, Rozzano, Italy. enrico.lugli@humanitasresearch.it.
  • Philip M; Lyell Immunopharma, South San Francisco, CA, USA. rlynn@lyell.com.
  • Rao A; Vanderbilt University Medical Center, Nashville, TN, USA. mary.philip@vumc.org.
  • Restifo NP; La Jolla Institute for Immunology, La Jolla, CA, USA. arao@lji.org.
  • Schietinger A; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA. arao@lji.org.
  • Schumacher TN; Moores Cancer Center, La Jolla, CA, USA. arao@lji.org.
  • Schwartzberg PL; Lyell Immunopharma, South San Francisco, CA, USA. nrestifo@lyell.com.
  • Sharpe AH; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schietia@mskcc.org.
  • Speiser DE; Netherlands Cancer Institute, Amsterdam, Netherlands. t.schumacher@nki.nl.
  • Wherry EJ; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. pams@nih.gov.
  • Youngblood BA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. arlene_sharpe@hms.harvard.edu.
  • Zehn D; Department of Oncology, University of Lausanne, Lausanne, Switzerland. daniel.speiser@unil.ch.
Nat Rev Immunol ; 19(11): 665-674, 2019 11.
Article em En | MEDLINE | ID: mdl-31570879
'T cell exhaustion' is a broad term that has been used to describe the response of T cells to chronic antigen stimulation, first in the setting of chronic viral infection but more recently in response to tumours. Understanding the features of and pathways to exhaustion has crucial implications for the success of checkpoint blockade and adoptive T cell transfer therapies. In this Viewpoint article, 18 experts in the field tell us what exhaustion means to them, ranging from complete lack of effector function to altered functionality to prevent immunopathology, with potential differences between cancer and chronic infection. Their responses highlight the dichotomy between terminally differentiated exhausted T cells that are TCF1- and the self-renewing TCF1+ population from which they derive. These TCF1+ cells are considered by some to have stem cell-like properties akin to memory T cell populations, but the developmental relationships are unclear at present. Recent studies have also highlighted an important role for the transcriptional regulator TOX in driving the epigenetic enforcement of exhaustion, but key questions remain about the potential to reverse the epigenetic programme of exhaustion and how this might affect the persistence of T cell populations.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Limite: Animals / Humans Idioma: En Revista: Nat Rev Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Limite: Animals / Humans Idioma: En Revista: Nat Rev Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda